Enteral Formula
OtherComplete feeding of study enteral formula, route and regime prescribed by the physician.
NCT Number: NCT01357200
This study will assess enteral feeding in an obese critically ill population with a higher protein whey based peptide formula.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
University of Kentucky, Lexington, Kentucky, United States
Assess enteral feeding goal with a higher protein whey based peptide formula in an obese critically ill population.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Complete feeding of study enteral formula, route and regime prescribed by the physician.
Time frame: up to 5 days
on all participants
Time frame: daily for up to 11 days
on all participants
Time frame: up to 5 days
on all participants
Time frame: daily for up to 11 days
on all participants
Time frame: daily for up to 11 days
on all participants
Société des Produits Nestlé (SPN)
Industry
Enteral Formula Tolerance in the Obese Critical Care Population
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06053216
Body Weight, Critical Illness
Blacktown, New South Wales, Australia
View Trial DetailsNCT00176306
Body Weight, Critical Illness
Lexington, Kentucky, United States
View Trial DetailsNCT07631429
Body Composition, Body Weight
Samsun, Atakum, Turkey (Türkiye)
View Trial DetailsNCT04612348
Critical Illness, Disease Attributes
Columbus, Ohio, United States
View Trial Details